AG
MRTX

Aperio Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Aperio Group’s Portfolio MRTX Stock Details MRTX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1.37M Buy
2020
Q3 		$760K Buy
2020
Q2 		$232K Buy
2020
Q1 		– Sell
2019
Q4 		$216K Buy
2019
Q3 		– Sell
2019
Q2 		$50K Buy